Cellular Dynamics International

About:

Cellular Dynamics International develops stem cell technologies for drug development and personalized medicine applications.

Website: http://www.cellulardynamics.com

Top Investors: Equity Group Investments, Wisconsin Alumni Research Foundation, Rose Ventures, Tactics II Stem Cell Ventures, Sixth Floor Investors

Description:

Cellular Dynamics International Inc., (CDI) is a developer and manufacturer of fully functioning cells in industrial quantities to precise specifications. CDI's proprietary products include true human cells in multiple cell types (iCell products), human induced pluripotent stem cells (iPSCs) and custom iPSCs and iCell products (MyCell Products). CDI's products provide standardized, easy-to-use, cost-effective access to the human cell, the smallest fully functioning operating unit of human biology. Customers use our products, among other purposes, for drug discovery and screening, to test the safety and efficacy of their small molecule and biological drug candidates, for stem cell banking, and in the research and development of cellular therapeutics.

Total Funding Amount:

$130M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Madison, Wisconsin, United States

Founded Date:

2004-01-01

Founders:

Craig T. January, Igor Slukvin, James A. Thomson, Thomas M. Palay, Timothy J. Kamp

Number of Employees:

51-100

Last Funding Date:

2013-07-03

IPO Status:

Delisted

Industries:

© 2025 bioDAO.ai